309 related articles for article (PubMed ID: 25214516)
1. Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286.
Tenorio AR; Chan ES; Bosch RJ; Macatangay BJ; Read SW; Yesmin S; Taiwo B; Margolis DM; Jacobson JM; Landay AL; Wilson CC;
J Infect Dis; 2015 Mar; 211(5):780-90. PubMed ID: 25214516
[TBL] [Abstract][Full Text] [Related]
2. Four Weeks of Treatment With Rifaximin Fails to Significantly Alter Microbial Diversity in Rectal Samples of HIV-Infected Immune Non-Responders (ACTG A5286) Which May be Attributed to Rectal Swab Use.
Williams BB; Green SJ; Bosch RJ; Chan ES; Jacobson JM; Margolis DM; Engen P; Landay AL; Wilson CC;
Pathog Immun; 2019; 4(2):235-250. PubMed ID: 31583331
[TBL] [Abstract][Full Text] [Related]
3. Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection.
Karris MY; Kao YT; Patel D; Dawson M; Woods SP; Vaida F; Spina C; Richman D; Little S; Smith DM
AIDS; 2014 Mar; 28(6):841-9. PubMed ID: 24401640
[TBL] [Abstract][Full Text] [Related]
4. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.
Wallet MA; Rodriguez CA; Yin L; Saporta S; Chinratanapisit S; Hou W; Sleasman JW; Goodenow MM
AIDS; 2010 Jun; 24(9):1281-90. PubMed ID: 20559035
[TBL] [Abstract][Full Text] [Related]
5. Systemic immune activation and microbial translocation in dual HIV/tuberculosis-infected subjects.
Toossi Z; Funderburg NT; Sirdeshmuk S; Whalen CC; Nanteza MW; Johnson DF; Mayanja-Kizza H; Hirsch CS
J Infect Dis; 2013 Jun; 207(12):1841-9. PubMed ID: 23479321
[TBL] [Abstract][Full Text] [Related]
6. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
[TBL] [Abstract][Full Text] [Related]
7. Long-term Use of Proton Pump Inhibitors Is Associated With Increased Microbial Product Translocation, Innate Immune Activation, and Reduced Immunologic Recovery in Patients With Chronic Human Immunodeficiency Virus-1 Infection.
Serpa JA; Rueda AM; Somasunderam A; Utay NS; Lewis D; Couturier JP; Breaux KG; Rodriguez-Barradas M
Clin Infect Dis; 2017 Oct; 65(10):1638-1643. PubMed ID: 29020215
[TBL] [Abstract][Full Text] [Related]
8. Increased microbial translocation in ≤ 180 days old perinatally human immunodeficiency virus-positive infants as compared with human immunodeficiency virus-exposed uninfected infants of similar age.
Papasavvas E; Azzoni L; Foulkes A; Violari A; Cotton MF; Pistilli M; Reynolds G; Yin X; Glencross DK; Stevens WS; McIntyre JA; Montaner LJ
Pediatr Infect Dis J; 2011 Oct; 30(10):877-82. PubMed ID: 21552185
[TBL] [Abstract][Full Text] [Related]
9. Microbial Translocation Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults With Suppressed Viremia.
Younas M; Psomas C; Reynes C; Cezar R; Kundura L; Portales P; Merle C; Atoui N; Fernandez C; Le Moing V; Barbuat C; Moranne O; Sotto A; Sabatier R; Fabbro P; Vincent T; Dunyach-Remy C; Winter A; Reynes J; Lavigne JP; Corbeau P
Front Immunol; 2019; 10():2185. PubMed ID: 31572392
[TBL] [Abstract][Full Text] [Related]
10. Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammation.
Torres B; Guardo AC; Leal L; Leon A; Lucero C; Alvarez-Martinez MJ; Martinez MJ; Vila J; Martínez-Rebollar M; González-Cordón A; Gatell JM; Plana M; García F
J Int AIDS Soc; 2014; 17(1):19246. PubMed ID: 25280865
[TBL] [Abstract][Full Text] [Related]
11. Increased gut microbial translocation in HIV-infected children persists in virologic responders and virologic failures after antiretroviral therapy.
Pilakka-Kanthikeel S; Huang S; Fenton T; Borkowsky W; Cunningham CK; Pahwa S
Pediatr Infect Dis J; 2012 Jun; 31(6):583-91. PubMed ID: 22333700
[TBL] [Abstract][Full Text] [Related]
12. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.
Rajasuriar R; Booth D; Solomon A; Chua K; Spelman T; Gouillou M; Schlub TE; Davenport M; Crowe S; Elliott J; Hoy J; Fairley C; Stewart G; Cameron P; Lewin SR
J Infect Dis; 2010 Oct; 202(8):1254-64. PubMed ID: 20812848
[TBL] [Abstract][Full Text] [Related]
13. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
14. Immune activation is associated with increased gut microbial translocation in treatment-naive, HIV-infected children in a resource-limited setting.
Pilakka-Kanthikeel S; Kris A; Selvaraj A; Swaminathan S; Pahwa S
J Acquir Immune Defic Syndr; 2014 May; 66(1):16-24. PubMed ID: 24378729
[TBL] [Abstract][Full Text] [Related]
15. Effects of Co-Trimoxazole on Microbial Translocation in HIV-1-Infected Patients Initiating Antiretroviral Therapy.
Vesterbacka J; Barqasho B; Häggblom A; Nowak P
AIDS Res Hum Retroviruses; 2015 Aug; 31(8):830-6. PubMed ID: 26059763
[TBL] [Abstract][Full Text] [Related]
16. Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection.
Schunter M; Chu H; Hayes TL; McConnell D; Crawford SS; Luciw PA; Bengmark S; Asmuth DM; Brown J; Bevins CL; Shacklett BL; Critchfield JW
BMC Complement Altern Med; 2012 Jun; 12():84. PubMed ID: 22747752
[TBL] [Abstract][Full Text] [Related]
17. Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy.
Routy JP; Angel JB; Patel M; Kanagaratham C; Radzioch D; Kema I; Gilmore N; Ancuta P; Singer J; Jenabian MA
HIV Med; 2015 Jan; 16(1):48-56. PubMed ID: 24889179
[TBL] [Abstract][Full Text] [Related]
18. Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART.
Stiksrud B; Nowak P; Nwosu FC; Kvale D; Thalme A; Sonnerborg A; Ueland PM; Holm K; Birkeland SE; Dahm AE; Sandset PM; Rudi K; Hov JR; Dyrhol-Riise AM; Trøseid M
J Acquir Immune Defic Syndr; 2015 Dec; 70(4):329-37. PubMed ID: 26258571
[TBL] [Abstract][Full Text] [Related]
19. Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trial.
d'Ettorre G; Baroncelli S; Micci L; Ceccarelli G; Andreotti M; Sharma P; Fanello G; Fiocca F; Cavallari EN; Giustini N; Mallano A; Galluzzo CM; Vella S; Mastroianni CM; Silvestri G; Paiardini M; Vullo V
PLoS One; 2014; 9(10):e109791. PubMed ID: 25340778
[TBL] [Abstract][Full Text] [Related]
20. Impact of HIV Infection and Anti-Retroviral Therapy on the Immune Profile of and Microbial Translocation in HIV-Infected Children in Vietnam.
Bi X; Ishizaki A; Nguyen LV; Matsuda K; Pham HV; Phan CT; Ogata K; Giang TT; Phung TT; Nguyen TT; Tokoro M; Pham AN; Khu DT; Ichimura H
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27490536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
